Login to Your Account

Pharma: Other News To Note

Friday, June 15, 2012
• Breckenridge Pharmaceutical Inc., of Boca Raton, Fla., and Alembic Pharmaceuticals Ltd., of Baroda, India, settled Paragraph IV patent litigation with Novartis AG, of Basel, Switzerland, concerning rivastigmine tartrate capsules, a generic version of Novartis' Exelon.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription